Your browser doesn't support javascript.
loading
Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer.
Chae, Chang-Suk; Sandoval, Tito A; Hwang, Sung-Min; Park, Eun Sil; Giovanelli, Paolo; Awasthi, Deepika; Salvagno, Camilla; Emmanuelli, Alexander; Tan, Chen; Chaudhary, Vidyanath; Casado, Julia; Kossenkov, Andrew V; Song, Minkyung; Barrat, Franck J; Holcomb, Kevin; Romero-Sandoval, E Alfonso; Zamarin, Dmitriy; Pépin, David; D'Andrea, Alan D; Färkkilä, Anniina; Cubillos-Ruiz, Juan R.
Afiliación
  • Chae CS; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York.
  • Sandoval TA; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York.
  • Hwang SM; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York.
  • Park ES; Department of Ophthalmology, Columbia University, New York, New York.
  • Giovanelli P; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, New York.
  • Awasthi D; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Salvagno C; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York.
  • Emmanuelli A; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York.
  • Tan C; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York.
  • Chaudhary V; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, New York.
  • Casado J; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York.
  • Kossenkov AV; HSS Research Institute and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, New York.
  • Song M; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.
  • Barrat FJ; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.
  • Holcomb K; Center for Systems and Computational Biology, The Wistar Institute, Philadelphia, Pennsylvania.
  • Romero-Sandoval EA; Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, and Department of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, Gyeonggi-do, Korea.
  • Zamarin D; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, New York.
  • Pépin D; HSS Research Institute and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, New York.
  • D'Andrea AD; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York.
  • Färkkilä A; Department of Anesthesiology, Pain Mechanisms Laboratory, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Cubillos-Ruiz JR; Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Discov ; 12(8): 1904-1921, 2022 08 05.
Article en En | MEDLINE | ID: mdl-35552618
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Lisofosfolípidos / Interferón Tipo I Límite: Female / Humans Idioma: En Revista: Cancer Discov Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Lisofosfolípidos / Interferón Tipo I Límite: Female / Humans Idioma: En Revista: Cancer Discov Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos